BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$665M |
| 2 |
Apple
AAPL
|
+$408M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$402M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$223M |
| 5 |
NVIDIA
NVDA
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$970M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$389M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$350M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.77% |
| 2 | Consumer Discretionary | 6.67% |
| 3 | Healthcare | 6.55% |
| 4 | Financials | 6.32% |
| 5 | Communication Services | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Dorian LPG
LPG
$1.95B
| $316K | ﹤0.01% |
20,762
-2,172
| -9% | -$34.4K |
|
2727
Red Robin
RRGB
$183M
| $315K | ﹤0.01% |
39,272
+23,347
| +147% | +$252K |
|
2728
Marcus & Millichap
MMI
$1.2B
| $313K | ﹤0.01% |
8,472
-759
| -8% | -$33K |
|
2729
Oramed Pharmaceuticals
ORMP
$182M
| $313K | ﹤0.01% |
68,350
-6,691
| -9% | -$35.8K |
|
2730
Simulations Plus
SLP
$370M
| $313K | ﹤0.01% |
6,335
+1,845
| +41% | +$87.1K |
|
|
CNH
2731
CNH Industrial
CNH
$16.7B
| $312K | ﹤0.01% |
26,921
-65,713
| -71% | -$936K |
|
|
ZUO
2732
DELISTED
Zuora, Inc.
ZUO
| $311K | ﹤0.01% |
34,804
-26,483
| -43% | -$294K |
|
2733
Viasat
VSAT
$11.4B
| $311K | ﹤0.01% |
10,156
-1,225
| -11% | -$47.4K |
|
2734
Farmers & Merchants Bancorp
FMAO
$486M
| $309K | ﹤0.01% |
9,295
+9,156
| +6,587% | +$341K |
|
2735
CareDx
CDNA
$2.45B
| $307K | ﹤0.01% |
14,300
+9,520
| +199% | +$264K |
|
2736
Adaptive Biotechnologies
ADPT
$3.89B
| $307K | ﹤0.01% |
37,968
+29,483
| +347% | +$259K |
|
2737
Scansource
SCSC
$1.06B
| $307K | ﹤0.01% |
9,856
-1,856
| -16% | -$65.1K |
|
|
JBGS
2738
JBG SMITH
JBGS
$692M
| $305K | ﹤0.01% |
12,900
-4,582
| -26% | -$119K |
|
2739
Aurinia Pharmaceuticals
AUPH
$2.02B
| $305K | ﹤0.01% |
30,323
-26,008
| -46% | -$291K |
|
2740
CryoPort
CYRX
$766M
| $304K | ﹤0.01% |
9,812
+5,215
| +113% | +$139K |
|
2741
Wendy's
WEN
$1.65B
| $304K | ﹤0.01% |
16,098
-68,943
| -81% | -$1.31M |
|
2742
Insteel Industries
IIIN
$634M
| $303K | ﹤0.01% |
8,987
+1,211
| +16% | +$48.1K |
|
2743
Ducommun
DCO
$3.01B
| $302K | ﹤0.01% |
7,009
+1,324
| +23% | +$63.5K |
|
2744
Krystal Biotech
KRYS
$9.72B
| $301K | ﹤0.01% |
4,577
+2,236
| +96% | +$139K |
|
|
LKFT
2745
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $300K | ﹤0.01% |
+5,369
| New | +$318K |
|
2746
BGC Group
BGC
$5.2B
| $299K | ﹤0.01% |
88,768
+16,364
| +23% | +$57K |
|
2747
Origin Bancorp
OBK
$1.69B
| $299K | ﹤0.01% |
7,695
+3,189
| +71% | +$126K |
|
2748
Dine Brands
DIN
$440M
| $297K | ﹤0.01% |
4,568
-227
| -5% | -$16.2K |
|
2749
1st Source
SRCE
$2.13B
| $295K | ﹤0.01% |
6,501
+2,788
| +75% | +$126K |
|
2750
1-800-Flowers.com
FLWS
$261M
| $295K | ﹤0.01% |
31,019
-17,177
| -36% | -$190K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2022 Portfolio in Review
As of Q2 2022, BNP Paribas Financial Markets held 4,360 positions worth $64.1B, down 14% from $74.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets's Q2 2022 filing shows 217 new, 1,899 increased, 1,581 reduced and 272 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M. The largest sale was Invesco QQQ Trust, an estimated $1.87B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2022 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2022, an estimated $665M increase.
- BNP Paribas Financial Markets's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.87B.
- BNP Paribas Financial Markets fully exited Warner Bros in Q2 2022, selling an estimated $27.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $64.1B portfolio in Q2 2022.
- BNP Paribas Financial Markets opened 217 new positions and closed 272 in Q2 2022.
- BNP Paribas Financial Markets's portfolio value fell 14% quarter-over-quarter to $64.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.